Ethical issues in human germline gene editing: a perspective from China

Area of Science:

• Bioethics
• Genetics
• Science Policy

Background:

• Germline gene modification and embryo research present complex ethical challenges.
• Rapid advancements in genetic technologies like CRISPR necessitate updated governance.
• Existing regulatory frameworks require strengthening for effective oversight.

Purpose of the Study:

• To highlight the urgent need for China to establish a comprehensive regulatory and ethical framework for genetic and embryo research.
• To analyze diverse public, scholarly, and policymaker opinions on new genetic technologies in China.
• To advocate for China's active participation in developing international norms for genetic research.

Main Methods:

• Policy analysis of existing Chinese regulations.
• Documentation of diverse stakeholder opinions on genetic technologies.
• Review of international scientific and ethical guidelines.

Main Results:

• China's current regulatory framework for genetic and embryo research needs enhancement, particularly in compliance oversight and review criteria.
• Significant variation in opinions exists among Chinese public, scholars, and policymakers regarding new genetic technologies.
• Complete international consensus on germline gene modification and embryo research is unlikely due to differing national regulations.

Conclusions:

• China must develop its own robust regulatory and ethical framework for genetic and embryo research, informed by both domestic and international discussions.
• Harmonization of international regulations, rather than complete consensus, should be the goal, with China's perspective being crucial.
• Effective governance requires acknowledging and accommodating China's unique position in the global development of genetic technologies and ethical standards.